Commonwealth Equity Services, LLC
- SEC CIK
- 0000312272
- Latest filing
- Jul 29, 2026
XFOR holding history
X4 Pharmaceuticals, Inc in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XFOR overviewAll 13F holders of XFORFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −842−100.0% | Sold outConverted for a 1-for-30 split | Holders |
| Q1 2025 | 25,250 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 25,250 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 25,250 | $17.0K | <0.1% | +150+0.6% | Added | Holders |
| Q2 2024 | 25,100 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 25,100 | $35.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 25,100 | $21.0K | <0.1% | −1,650−6.2% | Reduced | Holders |
| Q3 2023 | 26,750 | $29.0K | <0.1% | +4,250+18.9% | Added | Holders |
| Q2 2023 | 22,500 | $44.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 22,500 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 22,500 | $22.0K | <0.1% | +22,500 | New | Holders |